King of Prussia, PA, United States of America

Jianghe Deng


Average Co-Inventor Count = 10.5

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Collegeville, PA (US) (2011)
  • King of Prussia, PA (US) (2013)

Company Filing History:


Years Active: 2011-2013

Loading Chart...
2 patents (USPTO):

Title: Jianghe Deng: Innovator in Pharmaceutical Chemistry

Introduction

Jianghe Deng is a notable inventor based in King of Prussia, PA (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on chemical compounds and receptor antagonists. With a total of 2 patents, his inventions are aimed at addressing critical health issues.

Latest Patents

Deng's latest patents include novel indole carboxamide derivatives, which are designed to inhibit IKK2 activity. These compounds are particularly relevant for treating disorders such as rheumatoid arthritis, asthma, and chronic obstructive pulmonary disease (COPD). The invention also encompasses pharmaceutical compositions that utilize these compounds for effective treatment. Another significant patent involves IL-8 receptor antagonists, which are useful in treating diseases mediated by the chemokine Interleukin-8 (IL-8).

Career Highlights

Jianghe Deng is currently associated with GlaxoSmithKline LLC, where he continues to advance his research and development efforts. His work has the potential to impact various therapeutic areas, making him a valuable asset in the pharmaceutical industry.

Collaborations

Deng has collaborated with notable colleagues, including Katherine L. Widdowson and Jeffrey K. Kerns, enhancing the scope and impact of his research.

Conclusion

Jianghe Deng's innovative contributions to pharmaceutical chemistry demonstrate his commitment to improving health outcomes through scientific research. His patents reflect a deep understanding of complex biological mechanisms and a dedication to developing effective treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…